Systematic review | Open | Open Peer Review | Published:
The effectiveness of evidence summaries on health policymakers and health system managers use of evidence from systematic reviews: a systematic review
Implementation Sciencevolume 11, Article number: 162 (2016)
Systematic reviews are important for decision makers. They offer many potential benefits but are often written in technical language, are too long, and do not contain contextual details which make them hard to use for decision-making. There are many organizations that develop and disseminate derivative products, such as evidence summaries, from systematic reviews for different populations or subsets of decision makers. This systematic review aimed to (1) assess the effectiveness of evidence summaries on policymakers’ use of the evidence and (2) identify the most effective summary components for increasing policymakers’ use of the evidence. We present an overview of the available evidence on systematic review derivative products.
We included studies of policymakers at all levels as well as health system managers. We included studies examining any type of “evidence summary,” “policy brief,” or other products derived from systematic reviews that presented evidence in a summarized form. The primary outcomes were the (1) use of systematic review summaries in decision-making (e.g., self-reported use of the evidence in policymaking and decision-making) and (2) policymakers’ understanding, knowledge, and/or beliefs (e.g., changes in knowledge scores about the topic included in the summary). We also assessed perceived relevance, credibility, usefulness, understandability, and desirability (e.g., format) of the summaries.
Our database search combined with our gray literature search yielded 10,113 references after removal of duplicates. From these, 54 were reviewed in full text, and we included six studies (reported in seven papers) as well as protocols from two ongoing studies. Two studies assessed the use of evidence summaries in decision-making and found little to no difference in effect. There was also little to no difference in effect for knowledge, understanding or beliefs (four studies), and perceived usefulness or usability (three studies). Summary of findings tables and graded entry summaries were perceived as slightly easier to understand compared to complete systematic reviews. Two studies assessed formatting changes and found that for summary of findings tables, certain elements, such as reporting study event rates and absolute differences, were preferred as well as avoiding the use of footnotes.
Evidence summaries are likely easier to understand than complete systematic reviews. However, their ability to increase the use of systematic review evidence in policymaking is unclear.
The protocol was published in the journal Systematic Reviews (2015;4:122)
Policymakers are increasingly utilizing systematic reviews for decision-making [1–4]. The shift from single studies has occurred because systematic reviews offer additional benefits to policymakers, such as having lower risk of bias than other studies and offering more confidence in results than single studies . However, since systematic reviews are often written using technical language, lack important contextual information, and can be quite long, research groups and organizations have begun creating summaries of the evidence [4, 5]. A needs assessment conducted by Evidence Aid found that while complete systematic reviews were perceived to be useful for workers “on the ground” (i.e., NGOs, health care providers), summaries containing contextual information were considered helpful for decision-making about the applicability of the findings to their local setting .
There are several organizations that develop and disseminate evidence summaries for different populations or subsets of decision makers. For example, within the Cochrane Collaboration, the Evidence Aid Project was developed in response to the 2004 Indian Ocean Tsunami as a means of providing decision makers and health practitioners on the ground with summaries of the best available evidence needed to respond to emergencies and natural disasters .
SUPPORT summaries were developed for policymakers in low- and middle-income countries (LMICs) making decisions about maternal and child health programs and interventions (http://supportsummaries.org/). Health Systems Evidence provides a one-stop shop for systematic reviews related to health systems including policy briefs for policymakers and other stakeholders (www.healthsystemsevidence.org/). Other examples include Cochrane Summaries (http://www.cochrane.org/evidence), Communicate to vaccinate (COMMVAC) (http://www.commvac.com), and Rx for change (https://www.cadth.ca/rx-change). A document analysis conducted by Adam et al. identified 16 organizations involved in the production of summaries for policymakers in LMICs . These summaries are identified using many different terms including evidence summaries, policy briefs, briefing papers, briefing notes, evidence briefs, abstracts, summary of findings, and plain language summaries  but often contain summarized evidence from systematic reviews. They are intended to assist decision makers in understanding the evidence and encourage its use in their decision-making. These user-friendly formats highlight the policy-relevant information and allow policymakers to quickly scan the document for relevance [2, 8]. The various products have some differences. For example, abstracts, evidence summaries, and summary of findings tables summarize evidence from a single systematic review while policy briefs utilize evidence from one or more systematic reviews and may use additional sources to provide contextual or economic information .
Evidence on the usefulness and effectiveness of systematic review derivatives is lacking. Previously conducted systematic reviews have looked at interventions to increase the use of systematic reviews among decision makers; however, these have focused on the use of complete systematic reviews in decision-making, and none focused specifically on derivatives of systematic reviews. For example, one systematic review examined the effectiveness of interventions for improving the use of systematic reviews in decision-making by health system managers, policymakers, and clinicians . This review included eight studies, and the authors concluded that information provided as a single, clear message may improve evidence-based practice, but increasing awareness and knowledge of systematic review evidence might require a multi-faceted intervention. Similarly, another systematic review assessed interventions encouraging the use of systematic reviews by health policymakers and managers . Four studies were included, and the authors concluded that future research should identify how systematic reviews are accessed and the formats used to present the information. A systematic review by Wallace et al. found that the barriers, facilitators, and interventions that impact systematic review uptake found that a description of benefits as well as harms and costs and the use of a graded entry approach (in which evidence is available as a one-page summary, three-page summary, or 25-page full report) facilitated systematic review use by policymakers . Similarly, a systematic review by Oliver et al. also assessed barriers and facilitators to the use of research by policymakers; they found that access to high-quality, relevant research as well as collaboration between researchers and policymakers were the most important factors for increasing research use .
This review aimed to assess the effectiveness of systematic review summaries on increasing policymakers’ use of systematic review evidence and to identify the components or features of these summaries that are most effective . We present an overview of the available evidence on systematic review derivative products.
The objectives of this review were to (1) assess the effectiveness of evidence summaries on policy-makers’ use of the evidence and (2) identify the most effective summary components for increasing policy-makers’ use of the evidence.
We developed and published an a priori protocol for this systematic review .
Information specialists (APA, HC) developed and translated the search strategy using the PRESS Guideline .
We used the search strategy developed by Perrier et al. and Murthy et al. for their systematic reviews of interventions to encourage the use of systematic reviews by health managers and policymakers to inform our search [9, 10]. We expanded the Perrier search by including additional databases, as suggested by John Eyres, of the International Initiative for Impact Evaluation (3ie) and the Campbell International Development Review Group. These included Global Health Library (from WHO), Popline, Africa-wide, Public Affairs Information Service, Worldwide Political Science Abstracts, Web of Science, and DfiD (Research for Development Database). The search strategies were translated using each database platform’s command language and appropriate search fields. Both controlled vocabulary terms and text words were used for the search concepts of policymaking, evidence synthesis, systematic reviews, knowledge translation, and dissemination. No date restrictions were used. The complete MEDLINE search strategy is available in Additional file 1.
Searching other resources
We identified and searched websites of research groups and organizations which produce evidence summaries building on the list of organizations identified by Adam et al. . We searched for unpublished studies evaluating the effectiveness of the systematic review derivatives in increasing policymakers’ understanding (e.g., Health Systems Evidence, the Canadian Agency For Drugs And Technologies In Health, SUPPORT summaries). A complete list of gray literature sources is provided in Additional file 2.
We also checked the reference lists of included studies and related systematic reviews to identify additional studies. We contacted researchers to identify ongoing and completed/published work. The results of the search are reported in Fig. 1.
Study inclusion and exclusion criteria
Eligible studies included randomised controlled trials (RCTs), non-randomised controlled trials (NRCTs), controlled before-after (CBA) studies, and interrupted time series (ITS) studies.
We included studies whose participants were health policymakers at all levels. We defined policymakers as health ministers and their political staff, civil servants, health system managers, and health system stakeholders as civil society groups, patient groups, professional associations, non-governmental organizations, donors, and international agencies . We included populations involved in the development of clinical practice guidelines. To be included, the population had to be responsible for decision-making on behalf of a large jurisdiction or organization, and we did not include studies related to decision-making for an individual person or patient .
We included studies of interventions examining any type of “friendly front end”, “evidence summary”, or “policy brief” or other products derived from systematic reviews or guidelines based on systematic reviews that present evidence in a summarized form to policy-makers and health system managers. Interventions had to include a summary of a systematic review and be actively “pushed” to target users. We included any comparisons including active comparators (e.g., other summary formats) or no intervention.
Use of systematic review derivative product in decision-making (e.g., self-reported use of the evidence in policymaking, decision-making, as well as self-reported access of research, appraisal of research, or commissioning of further research within the decision-making process ). We included any type of use including instrumental use of research in decision-making (e.g., direct use of research), as well as conceptual use (e.g., using research to gain an understanding of a problem or intervention), and symbolic use (e.g., using research to confirm a policy/program already implemented) 
Understanding, knowledge, and/or beliefs (e.g., changes in knowledge scores about the topic included in the summary)
Perceived relevance of systematic review summaries
Perceived credibility of the summaries
Perceived usefulness and usability of systematic review summaries
o Perceptions and attitudes regarding the specific components of the summaries and their usefulness
Understandability of summaries
Desirability of summaries (e.g., layout, selection of images, etc.) 
Since some studies may use different terms to describe these outcomes, our team assessed each outcome and categorized them according to the above list.
Two reviewers independently screened titles and abstracts to identify relevant studies meeting the pre-specified inclusion criteria. The full text of each potentially included study was then screened independently by two authors.
Potential effect modifiers and reasons for heterogeneity
Meta-analysis was not possible, but if it had been, we planned to explore heterogeneity using forest plots and the I2 statistic according to guidance of the Cochrane Handbook for Systematic Reviews of Interventions . We were also thus unable to conduct planned meta-regression to assess the role of mediating factors, such as target audience of summary (e.g., focused on specific local context, generic summary), type of decision maker (e.g., federal policy-maker versus hospital administrator), and components of friendly front end (e.g., bulleted list, text, summary of findings table, causal chain).
Study quality assessment
The methodological quality was assessed using the risk of bias tool from the Cochrane Handbook for randomized trials. If we had identified eligible ITS, CBA, or NRS, we planned to use the Effective Practice and Organization of Care (EPOC) Review Group criteria for ITS and CBA studies [18, 19] and Risk Of Bias In Non-randomized Studies-of Interventions (ROBINS-I) [20, 21].
We used the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach to assess the quality of evidence for the outcomes reported in this review .
Data extraction strategy
The data extraction form was pre-tested, and included factors related to the population, intervention, comparison, and outcomes. Data extraction was completed by two authors independently using a structured Excel sheet. Disagreements on extractions were resolved by discussion and with a third member of the research team when necessary. The complete list of data extraction items has been reported elsewhere .
Data synthesis and presentation
Since it was not possible to combine the studies, we have presented the results for each study separately. We planned to conduct sensitivity analyses to assess the effects of incorporating these corrected analyses in our analysis. However, since we did not conduct a meta-analysis, this was not possible. We contacted the corresponding author of studies by email to ask for clarification on missing data and to ask for complete study results for eligible protocols.
Results of the search
The search strategy yielded 11,733 references (10,113 after removal of duplicates). Figure 1 depicts the results of the search and screening. During the title and abstract screening process, we excluded the 10,059 references for failing to meet one or more of our inclusion criteria. The remaining 50 references were reviewed as full text plus three additional references identified through reference list checking and one additional reference identified through gray literature searching. We excluded 45 studies that did not meet our eligibility criteria (see Additional file 3). We included six completed RCTs (reported in seven articles) in this review [23–28]. The characteristics of the included studies are summarized in Table 1.
The completed studies recruited participants from Canada (n = 1), Kenya (n = 1), USA (n = 1), internationally unspecified countries (46% from high-income countries) (n = 1), and countries in Europe, North America, South America, Africa, and Asia (n = 1) [23, 25–27, 29, 30]. One study did not report the participants’ country . Additionally, we identified two protocols for eligible studies: one RCT  and one CBA . These ongoing studies will be conducted in Canada (n = 1) and UK (n = 1) [31, 32]. The details of these studies are presented in Table 2.
Description of included studies
Details of the different evidence summary formats are reported in Table 3. Briefly, two studies assessed policy briefs [23, 26]; one assessed an “evidence summary” ; two assessed different formats of summary of findings tables, which are distinct table formats presenting the main findings of the review (absolute and relative effects for each important outcome) and quality of the evidence [28, 30]; and one compared an SOF table alone to a summary of findings table as part of a “graded entry” evidence summary (a short one-page summary, then a narrative report, followed by access to the complete systematic review) . Two studies assessed evidence summaries which included recommendations for programs or policies [23, 25], while the others did not specify whether recommendations were provided within the summary [26–28].
Carrasco-Labra et al. compared a standard format summary of findings table to a new format that presented some of the data in a different way as well as provided supplementary data . All the other included studies tested evidence summary formats using multiple arms. Brownson et al. compared four versions of a policy brief: a state-level, data-focused brief; a local-level, data-focused brief; a story-focused brief with a state-level data; and a story-focused brief with a local-level data .
Dobbins et al. had three groups. The first had access to the online database, the second received targeted, tailored messages in addition to access to an online database, and the third group received the same intervention as the second group plus access to a full-time knowledge broker .
Masset et al. and the companion paper by Beynon et al. assessed three versions of a policy brief. The first was the standard policy brief, the second was the same policy brief with an additional commentary by a sector expert (the Director of the institution who conducted the review), and the third was the same except the commentary was attributed to an unnamed research fellow [26, 29].
The study by Opiyo et al. compared a systematic review alone to a systematic review with a summary of findings table and a graded entry format that included a short interpretation of the main findings and conclusions (with a summary of findings table), a contextually framed narrative report, and the full systematic review .
Finally, the study by Vandvik et al. compared two versions of summary of findings tables with or without four formatting modifications (the placement of additional information, the placement of the overall rating for quality of evidence, the study event rates, and the absolute risk differences) .
Study quality assessment
The summary of the Risk of Bias assessments is presented in Fig. 2. Two studies were assessed as low risk of bias for random sequence generation [25, 30], and the others were assessed as unclear [23, 26–28]. For allocation concealment, four studies were assessed as unclear [23, 25–27, 29] and two studies assessed as low risk of bias [28, 30]. Baseline outcome measurements were similar and therefore low risk of bias in two studies [25, 26, 29] and unclear in four [23, 27, 28, 30]. Baseline characteristics were also similar in two studies [23, 26, 29] and unclear in the others [25, 27, 28, 30]. Incomplete outcome data was assessed as low risk of bias for four studies [25, 27, 28, 30] but high for two studies [23, 26, 29]. These two studies had very high rates of attrition; Brownson et al. had an overall response rate of 35%, and the Masset study had 50% attrition between the baseline and first follow-up . Prevention of knowledge of allocated interventions was assessed as unclear for four of the studies [23, 25–27, 29]. One study reported that panelists, data collection, and data analysis were blinded , and one reported that allocation was done in real time when the survey was completed, and these were therefore assessed as low risk of bias . Adequate protection from contamination was assessed as unclear for four studies. The Dobbins study included public health departments from across Canada, and therefore, little risk of contamination was expected , and Carrasco-Labra et al. reported that allocation was done in real time when completing the survey leaving little risk of contamination . All studies were assessed as low risk of bias for selective outcome reporting.
Most outcomes were assessed as moderate certainty of evidence using GRADE . The reasons for downgrading the evidence were due to unclear risk of bias or small sample sizes. Perceived desirability of the summaries was assessed as high certainty of evidence. The assessments are included in Table 4.
Evidence of effectiveness
We generated a summary of findings table for this review (Table 4). This is a narrative summary of all studies assessing a particular outcome domain, pooled across different policy brief formats.
Use of summaries in decision-making
Two studies assessed self-reported use of summaries in decision-making. First, Dobbins et al. assessed instrumental use; the change in global evidence-informed decision-making (EIDM) (defined as the extent to which research evidence was considered in a recent decision) after 18 months. The authors found that the intervention had no significant effect on EIDM. This study also reported on evidence-based public health policies and programs as a measure of the actual number of strategies, policies, and interventions for health body weight promotion among children that were implemented by the health department. For this outcome, the group that received the targeted, tailored messages had a significant increase in evidence-based public health policies and programs.
The study by Brownson et al. asked policymakers how likely they would be to use the evidence summary in decision-making classified as conceptual use of research. On a five-point Likert scale (where 1 is strongly disagree and 5 is strongly agree), there was little to no difference based on the type of policy brief (data-driven versus story-driven) (range 3.3 to 3.4). However, there were differences in self-reported likelihood of using the policy brief depending on the type of policymaker. Staff members reported being the most likely to use the story-focused brief with state-level data (mean rating of 3.4, 95% confidence interval (CI) 3.0 to 3.9) and the least likely to use the data-focused brief with state-level data (2.5, 95% CI 2.0 to 3.0). Legislators reported being the most likely to use the data-focused brief with state-level data (4.1, 95% CI 3.6 to 4.6) and the least likely to use the story-focused brief with state-level data (3.1, 95% CI 2.6 to 3.6) .
Understanding, knowledge, and/or beliefs
Carrasco-Labra et al. found that respondents receiving the new summary of findings format had a higher proportion of correct answers for almost all questions. These included the ability to interpret footnotes (risk difference (RD) 7%, p = 0.18), ability to determine risk difference (RD 63%, p = <0.001), understanding of quality of evidence and treatment effect (RD 62%, p = <0.001), understanding of the quality of evidence (RD 7%, p = 0.06), and ability to quantify risk (RD 6%, p = 0.06) . However, for one question, the ability to relate the number of participants and studies to outcomes, the group receiving the standard summary of findings scored slightly higher (RD −3%, p = 1.0).
The Masset study examined changes in beliefs about the effectiveness of the intervention as well as the strength of the evidence included in the policy briefs. The authors found that the policy brief increased the number of participants who had an opinion about the strength of the evidence (e.g., those who did not have an opinion at baseline formed an opinion based on the policy brief) but was less effective in changing participants’ ratings of the strength of the evidence or the effectiveness of the intervention . The policy brief did not change the opinions of those who had an opinion at baseline about the evidence and effectiveness.
The Opiyo study found little to no difference between the interventions for the odds of correct responses and questions about the intervention (adjusted odds ratio (OR) for summary of findings table compared to systematic review alone was 0.59, 95% CI 0.32 to 1.07, and for graded entry format compared to systematic review alone OR 0.66, 95% CI 0.36 to 1.21); however, both of these indicated that the odds of correct responses were higher for the groups who received an evidence summary or summary of findings . However, when comparing groups of participants, both the summary of findings tables and the graded entry formats slightly improved understanding for policymakers (summary of findings table compared to systematic review alone adjusted OR 1.5, 95% CI 0.15 to 15.15 and for graded entry format compared to systematic review alone, 1.5 (0.64 to 3.54)) .
Finally, Vandvik et al. reported that there was little to no difference in participants’ understanding of information in the different table formats for most items (range 80 to 97% for table A compared to 69 to 92% for table B, p values from 0.26 to 0.86) However, those with table A had higher scores for two items: time period for risk estimates (58% compared to 11%, p < 0.0001) and the range in which the effect may lie (95% versus 54%, p < 0.0001) .
Credibility of the summaries
Brownson et al. reported little to no differences in credibility between the different intervention formats. The mean scores for perceived credibility ranged from 4.4 to 4.5 on a five-point Likert scale . For different policymaker groups, there were also little to no differences with mean scores ranging from 4.2 to 4.5 for staff members, 4.3 to 4.7 for legislators, and 4.3 to 4.6 for executives .
The Masset study assessed how convincing the policy brief was, how robust the methodology was, and how strong the evidence was. Participants who had stronger beliefs about the evidence at baseline rated the policy brief more favorably .
Perceived usefulness and usability of the summaries
The Carrasco-Labra study reported that the new summary of findings format was more accessible than the standard format . This was assessed by asking respondents about their ease of finding the information about the effects (MD 0.4, SE 0.19, p = 0.04) and ease of understanding the information (MD 0.5, SE 0.2, p = 0.011). The respondents also reported that the new format displayed results in a way that was more helpful for decision-making (MD 0.5, SE 0.18, p = 0.011).
Opiyo et al. measured this outcome by assessing the “value and accessibility” of each intervention. The graded entry format received a higher mean score than the systematic review alone (adjusted mean difference (MD) 0.52 (95% CI 0.06 to 0.99). There was little to no difference in effect when comparing the summary of findings table and the systematic review alone (MD −0.11, 95% CI −0.71 to 0.48) .
Vandvik et al. reported that accessibility of information for quality of evidence as well as absolute and relative effects was rated similarly with no significant differences between groups . Only pooled results were presented.
Perceived understandability of the summaries
All the groups in the Brownson et al. study reported that the summaries were easy to understand . The mean ratings ranged from 4.3 to 4.4 on a five-point Likert scale. For the different policymaker groups, there was little to no difference with mean scores ranging from 4.3 to 4.5 for staff members and legislators and 4.1 to 4.4 for executives .
The study by Opiyo et al. reported that 60% (95% CI 48 to 73%) of the participants found systematic reviews to be more difficult to read than the narrative reports included in the graded entry formats. Fifty-one percent (95% CI 38 to 63%) compared to 26% (95% CI 15 to 37%) found the systematic reviews to be easier to read than the summary of findings tables, while 53% (95% CI 41 to 65%) compared to 25% (95% CI 14 to 36%) preferred the narrative report format (graded entry) to the full systematic review .
Perceived desirability of the summaries
The two studies of different summary of findings formats assessed this outcome. One study found that participants preferred the presentation of study event rates versus not having them (median 1, interquartile range (IQR) 1, on 1–7 scale, where 1 was strong preference for and 7 was strong preference against), absolute risk differences versus presentation of absolute risks (median 2, IQR 3), and having the additional information embedded in table versus having it as footnotes (median 1, IQR 2). No significant differences found for the placement of the column for overall quality of evidence (either as the final column or before the effect size) or the overall table format (differing by column headings and order of columns) .
The other study found that overall, respondents preferred the new summary of findings format (MD 2.8, SD 1.6) .
None of the included studies reported on policymakers’ perceived relevance of the summaries.
The organizational research culture was found to influence the effect of the intervention on evidence-based public health policies and programs in one study which found that tailored, targeted messages were more effective than access to a database alone (healthevidence.ca) or access to a knowledge broker when the organization valued research evidence in decision-making .
The Carrasco-Labra study found that the number of years of experience of the respondents modified the effect on understanding by more than 10% (adjusted OR 1.83; 95% CI 0.91 to 3.67) for the questions about the ability to determine a risk difference. For the question assessing whether respondents understand the quality of evidence and treatment effect combined, the authors found that years of experience, familiarity with GRADE, and level of training modified the effect by more than 10% (adjusted OR 0.72; 95% CI 0.20 to 2.56).
This review has summarized the evidence on the use of systematic review summaries in policymaking, policymakers’ understanding of systematic review evidence, and different components and design features. Overall, the results suggest that evidence summaries are likely easier to understand than complete systematic reviews. However, their ability to increase the use of systematic review evidence in policymaking is unclear. Six studies were included in this review. For our primary outcome, the use of systematic review evidence in decision-making, we found moderate certainty of evidence. One study found that targeted, tailored messages increased the number of evidence-based public health policies and programs; however, for the two studies that assessed effect on decision-making or likelihood of using the summary in decision-making, there was little to no difference between the intervention groups [23, 25]. For the secondary outcome, understanding, knowledge, and beliefs, there was little to no difference in effect and moderate certainty of evidence in three of the four studies assessing this outcome [26–28] although there was a slight increase in understanding for summary of findings tables and graded entry formats compared to systematic reviews alone. The fourth study found that those provided with an alternate version of the summary of findings had greater understanding . For perceived desirability of summaries, we found high certainty of evidence. In summary of findings tables, one study found that the alternate version was preferred,  and the other study found that certain formatting elements were preferred such as study event rates, absolute risk differences, and additional information provided in the table and not in footnotes . One study found the alternate format to be more accessible than the standard format ; however, the other study assessing formatting changes found little to no difference in effect for perceived usefulness . For perceived usefulness and usability of the summaries, we found low certainty of evidence. The graded entry summary was rated higher than a systematic review alone for usability . Summaries were perceived as easier to understand than systematic reviews (moderate certainty of evidence) [23, 27]. There was little to no difference in effect for different versions of the policy brief (data-driven versus story-driven, local- versus state-level data; moderate certainty of evidence) for perceived credibility of the summaries .
Our primary outcome, the policymakers’ use of systematic review evidence in decision-making, is challenging to measure. Other studies have noted the inherent challenges in measuring this outcome since many factors contribute to decision-making, and it is often difficult for an individual to identify which factors had a role in their final decision [25, 33]. Instead of determining the actual use of research in decision-making, studies assessed self-reported use of research or other outcomes, such as perceived credibility or relevance, since these may affect the likelihood of research use in decision-making.
Our review is limited by the indexing of studies in this area. To address this issue, we conducted a broad search using search strategies adapted from similar systematic review. Our search identified over 10,000 references, but we had a low yield of included studies. The methods used in the included studies were poorly reported. For example, only two studies adequately reported on random sequence generation or allocation concealment, which means that most studies have unclear risk of bias.
More research is needed to determine whether evidence summaries can increase the use of systematic reviews by policymakers and health system managers. We identified two protocols for ongoing studies which are promising as the results of these studies will enhance the available evidence about the effectiveness of evidence summaries [31, 32]. We also identified other relevant studies assessing the effectiveness of systematic review derivatives that did not use an eligible study design (e.g., used interviews or other methods without a control group) [5, 21]. One of these studies was intended to be a RCT and process evaluation but was not eligible for our review because poor recruitment (only 15% of the planned sample) resulted in the termination of the trial . This demonstrates the difficulty with recruiting these types of participants. Recruitment for the process evaluation remained low, and the authors noted that those included are likely those already more interested in using systematic review derivatives . The authors noted that for future RCTs, recruitment may be more successful achieved from randomizing divisions versus individuals since the nature of policymaking is quite complex and often not completed at the individual level. Additionally, we identified other studies that were not focused on policymakers but rather, clinicians [34, 35] or the public . These studies demonstrated that evidence summaries can improve understanding of research evidence within these populations; however, use of evidence in decision-making was not assessed.
It is important to note that only two of the included studies compared the evidence summary to a full systematic review or access to a database of systematic reviews. The others compared different versions of evidence summaries and, in general, found little to no differences in the effects. Had these studies included systematic reviews as a control group, the results may be different. Additional research on the use of evidence summaries derived from systematic reviews is needed.
A previously conducted systematic review identified poor access to high-quality and relevant research as a barrier to the use of research evidence by policymakers . Evidence summaries can address this barrier by increasing access to systematic review evidence provided that policymakers are aware that these products are available. Our review has not identified the best way to disseminate these products although one study found that targeted, tailored messages improved research use by the policymakers . Future developers of systematic review products should collaborate with the policymakers to ensure that their summaries are relevant to those making decisions in practice . Future studies should include an assessment of delivery strategies since the effectiveness of the systematic review derivative product in practice will be impacted by the policymakers’ knowledge of and access to the summaries themselves. Our included studies suggest that evidence summaries have a small effect on improving knowledge and understanding and should be created. However, we have very little evidence to inform the design of evidence summaries since we only found a handful of different formats (none the same), and there was little to no difference between formats when compared directly.
The interventions assessed in the studies included in our review are quite diverse with a variety of outcome measures. We included a broad range of interventions to provide an overview of the evidence on systematic review derivative products. These products have important differences in design and source material. For example, a policy brief includes evidence from one or more systematic reviews and includes information from additional sources [4, 7], whereas a summary of findings table reports results for a single systematic review. We chose to include all systematic review derivative products since there are limited studies on a single product type. We recognize that this creates a challenge for interpreting the results since the interventions were quite different. Therefore, we have provided a narrative summary of each study and presented an overview of the available evidence.
International Initiative for Impact Evaluation
Controlled before-after studies
Canadian Institutes of Health Research
Communicate to vaccinate
Department for International Development
Grading of Recommendations Assessment, Development, and Evaluation
Intracluster correlation coefficient
Interrupted time series
Non-randomized controlled trial
Randomized controlled trial
World Health Organization
Welch V, Petticrew M, Tugwell P, Moher D, O’Neill J, et al. PRISMA-Equity 2012 Extension: reporting guidelines for systematic reviews with a focus on health equity. PLoS Med. 2012;9:e1001333.
Lavis JN, Davies HT, Gruen RL, Walshe K, Farquhar CM. Working within and beyond the Cochrane Collaboration to make systematic reviews more useful to healthcare managers and policy makers. Healthc Policy. 2006;1:21–33.
Petticrew M, Whitehead M, Macintyre SJ, Graham H, Egan M. Evidence for public health policy on inequalities: 1: the reality according to policymakers. J Epidemiol Community Health. 2004;58:811–6.
Moat KA, Lavis JN, Abelson J. How contexts and issues influence the use of policy-relevant research syntheses: a critical interpretive synthesis. Milbank Q. 2013;91:604–48.
Rosenbaum SE, Glenton C, Wiysonge CS, Abalos E, Mignini L, Young T, Althabe F, Ciapponi A, Marti SG, Meng Q, et al. Evidence summaries tailored to health policy-makers in low- and middle-income countries. Bull World Health Organ. 2011;89:54–61.
Kayabu B, Clarke M. The use of systematic reviews and other research evidence in disasters and related areas: preliminary report of a needs assessment survey. PLoS Curr Disasters. 2013. Edition 1. doi:10.1371/currents.dis.ed42382881b3bf79478ad503be4693ea.
Adam T, Moat KA, Ghaffar A, Lavis JN. Towards a better understanding of the nomenclature used in information-packaging efforts to support evidence-informed policymaking in low- and middle-income countries. Implement Sci. 2014;9:67.
Lavis J, Davies H, Oxman A, Denis JL, Golden-Biddle K, Ferlie E. Towards systematic reviews that inform health care management and policy-making. J Health Serv Res Policy. 2005;10 Suppl 1:35–48.
Murthy L, Shepperd S, Clarke MJ, Garner SE, Lavis JN, Perrier L, Roberts NW, Straus SE. Interventions to improve the use of systematic reviews in decision-making by health system managers, policy makers and clinicians. Cochrane Database Syst Rev. 2012;9:CD009401.
Perrier L, Mrklas K, Lavis JN, Straus SE. Interventions encouraging the use of systematic reviews by health policymakers and managers: a systematic review. Implement Sci. 2011;6:43.
Wallace J, Byrne C, Clarke M. Making evidence more wanted: a systematic review of facilitators to enhance the uptake of evidence from systematic reviews and meta-analyses. Int J Evid Based Healthc. 2012;10:338–46.
Oliver K, Innvar S, Lorenc T, Woodman J, Thomas J. A systematic review of barriers to and facilitators of the use of evidence by policymakers. BMC Health Serv Res. 2014;14:2.
Petkovic J, Welch V, Tugwell P. Do evidence summaries increase policy-makers’ use of evidence from systematic reviews: a systematic review protocol. Syst Rev. 2015;4:122.
Sampson M, McGowan J, Lefebvre C, Moher D, Grimshaw J. PRESS: Peer Review of Electronic Search Strategies. Ottawa: Canadian Agency for Drugs and Techonologies in Health; 2008.
Lavis JN, Posada FB, Haines A, Osei E. Use of research to inform public policymaking. Lancet. 2004;364:1615–21.
Redman S, Turner T, Davies H, Williamson A, Haynes A, Brennan S, Milat A, O’Connor D, Blyth F, Jorm L, Green S. The SPIRIT Action Framework: a structured approach to selecting and testing strategies to increase the use of research in policy. Soc Sci Med. 2015;136–137:147–55.
Amara N, Ouimet M, Landry R. New evidence on instrumental, conceptual, and symbolic utilization of university research in government agencies. Science Communication. 2004;26:75–106.
Cochrane handbook for systematic reviews of interventions. (Higgins JPT, Green S eds.), vol. Version 5.1.0: The Cochrane Collaboration; 2011.
Ballini L, Bero L, Durieux P, Eccles MP, Grimshaw J, Gruen RL, Lewin S, Mayhew A, Munabi-Babigumira S, O’Connor AD, et al. Cochrane effective practice and organisation of care group. In: About The Cochrane Collaboration (Cochrane Review Groups (CRGs). 2011.
Sterne JAC, Higgins JPT, Reeves BC. ACROBAT-NRSI obotdgf: A Cochrane Risk of Bias Assessment Tool: for Non-Randomized Studies of Interventions (ACROBAT-NRSI). 2014.
Wilson MG, Grimshaw JM, Haynes RB, Hanna SE, Raina P, Gruen R, Ouimet M, Lavis JN. A process evaluation accompanying an attempted randomized controlled trial of an evidence service for health system policymakers. Health Res Policy Syst. 2015;13:78.
Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, Norris S, Falck-Ytter Y, Glasziou P, DeBeer H, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64:383–94.
Brownson RC, Dodson EA, Stamatakis KA, Casey CM, Elliott MB, Luke DA, Wintrode CG, Kreuter MW. Communicating evidence-based information on cancer prevention to state-level policy makers. J Natl Cancer Inst. 2011;103:306–16.
What is a systematic review [http://www.campbellcollaboration.org/what_is_a_systematic_review/index.php]. Accessed 3 Aug 2016.
Dobbins M, Hanna SE, Ciliska D, Manske S, Cameron R, Mercer SL, O’Mara L, DeCorby K, Robeson P. A randomized controlled trial evaluating the impact of knowledge translation and exchange strategies. Implement Sci. 2009;4:61.
Masset E, Gaarder M, Beynon P, Chapoy C. What is the impact of a policy brief? Results of an experiment in research dissemination. Journal of Development Effectiveness. 2013;5:50–63.
Opiyo N, Shepperd S, Musila N, Allen E, Nyamai R, Fretheim A, English M. Comparison of alternative evidence summary and presentation formats in clinical guideline development: a mixed-method study. PLoS ONE. 2013;8:e55067.
Vandvik PO, Santesso N, Akl EA, You J, Mulla S, Spencer FA, Johnston BC, Brozek J, Kreis J, Brandt L, et al. Formatting modifications in GRADE evidence profiles improved guideline panelists comprehension and accessibility to information. A randomized trial. J Clin Epidemiol. 2012;65:748–55.
Beynon P, Chapoy C, Gaarder M, Masset E (Eds.): What difference does a policy brief make? Full report of an IDS, 3ie, Norad study: Institute of Development Studies and the International Initiative for Impact Evaluation (3ie); 2012.
Carrasco-Labra A, Brignardello-Petersen R, Santesso N, Neumann I, Mustafa RA, Mbuagbaw L, Etxeandia Ikobaltzeta I, De Stio C, McCullagh LJ, Alonso-Coello P, et al. Improving GRADE evidence tables part 1: a randomized trial shows improved understanding of content in summary of findings tables with a new format. J Clin Epidemiol. 2016;74:7–18.
Wilson MG, Lavis JN, Grimshaw JM, Haynes RB, Bekele T, Rourke SB. Effects of an evidence service on community-based AIDS service organizations’ use of research evidence: a protocol for a randomized controlled trial. Implement Sci. 2011;6:52.
Wilson PM, Farley K, Thompson C, Chambers D, Bickerdike L, Watt IS, Lambert M, Turner R: Effects of a demand-led evidence briefing service on the uptake and use of research evidence by commissioners of health services: protocol for a controlled before and after study. Implementation Sci. 2015;10:7. doi:10.1186/s13012-014-0199-4.
Dobbins M, Jack S, Thomas H, Kothari A. Public health decision-makers’ informational needs and preferences for receiving research evidence. Worldviews Evid Based Nurs. 2007;4:156–63.
Noor RA. Health research oversight in Africa. Acta Trop. 2009;112 Suppl 1:S63–70.
Perrier L, Persaud N, Thorpe KE, Straus SE. Using a systematic review in clinical decision-making: a pilot parallel, randomized controlled trial. Implement Sci. 2015;10:118.
Oermann MH, Roop JC, Nordstrom CK, Galvin EA, Floyd JA. Effectiveness of an intervention for disseminating Cochrane reviews to nurses. Urol Nurs. 2009;29:35–9. 54.
The authors thank Christian Charbonneau who assisted with the screening and data extraction.
This work is funded by JP’s CIHR Doctoral Research Award. The funder had no role in the development of this protocol.
Availability of data and materials
The data extraction form available on request from the authors.
JP, VW, and PT conceived the study. APA, HC, and MY developed, translated, and ran the search strategy. MHJ and JP completed the screening and data extraction. MHJ and JP summarized the results. JP wrote the first draft, and all authors revised the manuscript. All authors read and approved the final manuscript.
The authors declare that they have no competing interests.
Consent for publication
Ethics approval and consent to participate